Compare SLB & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLB | CAH |
|---|---|---|
| Founded | 1926 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9B | 55.6B |
| IPO Year | 1996 | 1994 |
| Metric | SLB | CAH |
|---|---|---|
| Price | $52.62 | $235.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | $57.85 | ★ $232.27 |
| AVG Volume (30 Days) | ★ 12.0M | 2.0M |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.12% | 1.01% |
| EPS Growth | N/A | ★ 12.09 |
| EPS | 1.02 | ★ 7.23 |
| Revenue | $30,440,000,000.00 | ★ $254,248,000,000.00 |
| Revenue This Year | $3.91 | $17.36 |
| Revenue Next Year | $6.20 | $9.06 |
| P/E Ratio | $51.58 | ★ $32.52 |
| Revenue Growth | 9.46 | ★ 14.23 |
| 52 Week Low | $31.64 | $145.87 |
| 52 Week High | $58.82 | $258.30 |
| Indicator | SLB | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 54.81 |
| Support Level | $48.32 | $196.64 |
| Resistance Level | $58.05 | $243.21 |
| Average True Range (ATR) | 1.76 | 6.18 |
| MACD | 0.52 | 0.42 |
| Stochastic Oscillator | 82.69 | 33.43 |
SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by Conrad and Marcel Schlumberger. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts nearly $3 billion in digital-related revenue.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.